Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1961 Aug;40(8 Pt 1-2):1421–1430. doi: 10.1172/JCI104373

COMPARISON OF EFFECTS OF PROTAMINE AND POLYBRENE, WITH SPECIAL EMPHASIS ON THE FACTOR VIII (ANTI-HEMOPHILIC GLOBULIN) DEFICIENCY INDUCED*

Herbert A Perkins 1,2, George Harkins 1,2, Frank Gerbode 1,2, Mary R Rolfs 1,2, D J Acra 1,2
PMCID: PMC292516  PMID: 13734399

Full text

PDF
1421

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSEN M. N., MENDELOW M., ALFANO G. A. A comparative study of heparin neutralization and the danger of blood clotting abnormalities with protamine and polybrene. J Thorac Cardiovasc Surg. 1960 May;39:613–618. [PubMed] [Google Scholar]
  2. BELL W. N., ALTON H. G. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature. 1954 Nov 6;174(4436):880–881. doi: 10.1038/174880a0. [DOI] [PubMed] [Google Scholar]
  3. BERGNA L. J. A simple method for the assay of factor VIII. Blood. 1960 May;15:637–645. [PubMed] [Google Scholar]
  4. BLUMBERG J. B., WINTERSCHEID L. C., DILLARD D. H., VETTO R. R., MERENDINO K. A. The clinical use of polybrene as an antiheparin agent in open heart surgery. J Thorac Cardiovasc Surg. 1960 Mar;39:330–336. [PubMed] [Google Scholar]
  5. BORCHGREVINK C. F., POOL J. G., STORMORKEN H. A new assay for factor V (proaccelerin-accelerin) using Russell's viper venom. J Lab Clin Med. 1960 Apr;55:625–632. [PubMed] [Google Scholar]
  6. BRECHER G., SCHNEIDERMAN M., CRONKITE E. P. The reproducibility and constancy of the platelet count. Am J Clin Pathol. 1953 Jan;23(1):15–26. doi: 10.1093/ajcp/23.1.15. [DOI] [PubMed] [Google Scholar]
  7. HICKS N. D., PITNEY W. R. A rapid screening test for disorders of thromboplastin generation. Br J Haematol. 1957 Apr;3(2):227–237. doi: 10.1111/j.1365-2141.1957.tb05790.x. [DOI] [PubMed] [Google Scholar]
  8. HOUGIE C. Anticoagulant action of protamine sulphate. Proc Soc Exp Biol Med. 1958 May;98(1):130–133. doi: 10.3181/00379727-98-23963. [DOI] [PubMed] [Google Scholar]
  9. KEATS A. S., COOLEY D. A., TELFORD J. Relative antiheparin potency of polybrene and protamine in patients undergoing extracorporeal circulation. J Thorac Cardiovasc Surg. 1959 Sep;38:362–368. [PubMed] [Google Scholar]
  10. LILLEHEI C. W., STERNS L. P., LONG D. M., LEPLEY D., Jr Comparative study of polybrene and protamine for heparin neutralization in open heart surgery. Ann Surg. 1960 Jan;151:11–16. [PMC free article] [PubMed] [Google Scholar]
  11. PERKINS H. A., OSBORN J. J., HURT R., GERBODE F. Neutralization of heparin in vivo with protamine; a simple method of estimating the required dose. J Lab Clin Med. 1956 Aug;48(2):223–226. [PubMed] [Google Scholar]
  12. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  13. ROTHNIE N. G., KINMONTH J. B. Bleeding after perfusion for open heart surgery. Importance of unneutralized heparin and its proper correction. Br Med J. 1960 Jan 9;1(5166):73–78. doi: 10.1136/bmj.1.5166.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. STEFANINI M. New one-stage procedures for the quantitative determination of prothrombin and labile factor. Am J Clin Pathol. 1950 Mar;20(3):233–240. doi: 10.1093/ajcp/20.3.233. [DOI] [PubMed] [Google Scholar]
  15. WARE A. G., STRAGNELL R. An improved one-stage prothrombin method. Am J Clin Pathol. 1952 Aug;22(8):791–797. doi: 10.1093/ajcp/22.8_ts.791. [DOI] [PubMed] [Google Scholar]
  16. WEISS W. A., GILMAN J. S., CATENACCI A. J., OSTERBERG A. E. Heparin neutralization with polybrene administered intravenously. J Am Med Assoc. 1958 Feb 8;166(6):603–607. doi: 10.1001/jama.1958.02990060041010. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES